Vertex Pharma (VRTX) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $510.72 --0%
EPS Growth %: -0.6%
Financial Fact:
Net loss: -39.54M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -0.6%
Financial Fact:
Net loss: -39.54M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q1 EPS of ($0.62), $0.13 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $138.5 million versus the consensus estimate of $142.38 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
- Turning Point Brands (TPB) PT Lowered to $90 at Oppenheimer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
